TrialCancer research2018

IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer.

Te-Chia Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.